title: Effects of potential probiotic Bacillus amyloliquefaciens [corrected] FPTB16 on systemic and cutaneous mucosal immune responses and disease resistance of catla (Catla catla).
abstract: Effects of dietary administration of Bacillus amyloliquefaciens FPTB16 on systemic and mucosal immunity and disease resistance of catla (Catla catla) against Edwardsiella tarda infection were evaluated in the present study. The laboratory maintained B. amyloliquefaciens was used to study antagonistic activity against fish pathogenic bacteria by agar well diffusion assay. Healthy catla were challenged by this bacterium for determination of its safety. For preparation of probiotic supplemented diet, the bacteria were added to the basal diet (control) at three different inclusion levels i.e., 1 × 10(9), 1 × 10(8) and 1 × 10(7) CFU/g diet. Fish (weight 25-30 g) were fed with these diets and various immune parameters and disease resistance study were conducted at 4 weeks and 8 weeks post-feeding. The bacterial antagonism study showed inhibition zone against E. tarda, Aeromonas hydrophila, Vibrio parahaemolyticus and V. harveyi. B. amyloliquefaciens was harmless to catla as neither mortalities nor morbidities were observed after the challenge. Study of different systemic and mucosal immunological parameters viz. superoxide anion production and nitric oxide production, myeloperoxidase content, lysozyme activity and total protein content showed significant enhancement (p < 0.05) in fish fed with 10(8) and 10(9) CFU/g B. amyloliquefaciens at both time points with the highest values observed in case of 10(9) CFU/g. For fish fed with 10(7) CFU/g B. amyloliquefaciens, all the parameters showed significant enhancement (p < 0.05) at both time points except the lysozyme activity of serum at 8 weeks. Diet containing 10(8) and 10(9) CFU/g B. amyloliquefaciens significantly enhanced (p < 0.05) the resistance of catla against bacterial challenge at both time points. These results collectively suggest that B. amyloliquefaciens is a potential probiotic species and can be used in aquaculture to improve health status and disease resistance with an optimal dietary supplementation of 10(9) CFU/g.
authors.affiliation: Department of Fish Health and Environment, College of Fisheries, Central Agricultural University, Lembucherra, Post Box No. 60, Agartala 799 001, Tripura, India.
authors.forename: Anushree
authors.initials: A
authors.lastname: Das
authors.forename: Khriezhato
authors.initials: K
authors.lastname: Nakhro
authors.forename: Supratim
authors.initials: S
authors.lastname: Chowdhury
authors.forename: Dibyendu
authors.initials: D
authors.lastname: Kamilya
mesh_terms: D000818:Animals; D017756:Aquaculture / Q000379:methods; D001407:Bacillus / Q000737:chemistry*; D003530:Cyprinidae / Q000276:immunology*; D019587:Dietary Supplements; D060467:Disease Resistance / Q000187:drug effects* / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D060226:Head Kidney / Q000276:immunology; D018928:Immunity, Mucosal / Q000187:drug effects* / Q000276:immunology; D009113:Muramidase / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D009195:Peroxidase / Q000378:metabolism; D019936:Probiotics / Q000008:administration & dosage / Q000494:pharmacology*; D013481:Superoxides / Q000378:metabolism
chemical_list: D013481:Superoxides; D009569:Nitric Oxide; D009195:Peroxidase; D009113:Muramidase
keywords: Bacillus amyloliquefaciens FPTB16; Catla (Catla catla); Disease resistance; Immune response; Probiotic